BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3856064)

  • 1. Augmentation of hematoporphyrin uptake and in vitro-growth inhibition of L1210 leukemia cells by succinylacetone.
    Ebert PS; Hess RA; Tschudy DP
    J Natl Cancer Inst; 1985 Mar; 74(3):603-8. PubMed ID: 3856064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of succinylacetone on growth and respiration of L1210 leukemia cells.
    Weinbach EC; Ebert PS
    Cancer Lett; 1985 Apr; 26(3):253-9. PubMed ID: 3995499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory activity of succinylacetone: studies with Walker 256 carcinosarcoma, Novikoff hepatoma and L1210 leukemia.
    Tschudy DP; Ebert PS; Hess RA; Frykholm BC; Atsmon A
    Oncology; 1983; 40(2):148-54. PubMed ID: 6828292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of hematin and growth of malignant murine erythroleukemia cells depleted of endogenous heme by succinylacetone.
    Ebert PS; Frykholm BC; Hess RA; Tschudy DP
    Cancer Res; 1981 Mar; 41(3):937-41. PubMed ID: 6936078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of hematin uptake in malignant, embryonic and normal cells.
    Ebert PS; Frykholm BC; Hess RA; Tschudy DP
    Cancer Biochem Biophys; 1983; 6(3):157-65. PubMed ID: 6573944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of succinylacetone.
    Tschudy DP; Hess RA; Frykholm BC; Blaese RM
    J Lab Clin Med; 1982 Apr; 99(4):526-32. PubMed ID: 7061925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heme synthesis in bone marrow cells by succinylacetone: effect on globin synthesis.
    Beru N; Sahr K; Goldwasser E
    J Cell Biochem; 1983; 21(2):93-105. PubMed ID: 6193131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells.
    Kessel D
    Cancer Res; 1981 Apr; 41(4):1318-23. PubMed ID: 7214321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta-Aminolevulinic acid dehydratase: is there a form unique to renal cortex?
    Roth KS; Spencer PD; Moses LC; Carter BE
    Enzyme; 1990; 43(1):17-25. PubMed ID: 2361489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-translational processing of myeloperoxidase is regulated by the availability of heme.
    Pinnix IB; Guzman GS; Bonkovsky HL; Zaki SR; Kinkade JM
    Arch Biochem Biophys; 1994 Aug; 312(2):447-58. PubMed ID: 8037458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol.
    Ishii T; Hishinuma I; Bannai S; Sugita Y
    J Cell Physiol; 1981 May; 107(2):283-93. PubMed ID: 7251686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Components of hematoporphyrin derivatives and their tumor-localizing capacity.
    Kessel D
    Cancer Res; 1982 May; 42(5):1703-6. PubMed ID: 7066890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. delta-Aminolevulinic acid dehydratase: effects of succinylacetone in rat liver and kidney in an in vivo model of the renal Fanconi syndrome.
    Wyss PA; Carter BE; Roth KS
    Biochem Med Metab Biol; 1992 Aug; 48(1):86-9. PubMed ID: 1524874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural, immunochemical, and cytochemical study of myeloperoxidase in myeloid leukemia HL-60 cells following treatment with succinylacetone, an inhibitor of heme biosynthesis.
    CastaƱeda VL; Parmley RT; Pinnix IB; Raju SG; Guzman GS; Kinkade JM
    Exp Hematol; 1992 Aug; 20(7):916-24. PubMed ID: 1321053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells.
    Ebert PS; Hess RA; Frykholm BC; Tschudy DP
    Biochem Biophys Res Commun; 1979 Jun; 88(4):1382-90. PubMed ID: 289386
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
    Creekmore SP; Zaharko DS
    Cancer Res; 1983 Nov; 43(11):5252-7. PubMed ID: 6616462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability to elicit rapid cytocidal effects on L1210 cells derived from porphyrin-injected mice following in vitro photoirradiation.
    Musser DA; Datta-Gupta N
    J Natl Cancer Inst; 1984 Feb; 72(2):427-34. PubMed ID: 6229668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.